Drug application
PREMPRO (PREMARIN;CYCRIN) (ESTROGENS, CONJUGATED, MEDROXYPROGESTERONE ACETATE)
Drugs@FDA NDA 020303 · WYETH PHARMS INC
Key facts
| Drug name | PREMPRO (PREMARIN;CYCRIN) |
|---|---|
| Active ingredients | ESTROGENS, CONJUGATED, MEDROXYPROGESTERONE ACETATE |
| Application type | NDA |
| Application number | 020303 |
| Company | WYETH PHARMS INC |
| Dosage forms | TABLET, ORAL-28 |
| Strength | 0.625MG,0.625MG;2.5MG,2.5MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Dec 30, 1994 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: